Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microgenesis is a private fertility-focused biotechnology and diagnostics company developing microbiome-based tools and personalized interventions for women with infertility and recurrent failed IVF. The company uses functional microbiome analysis, including microRNA signatures from fertility-biome swabs, to identify inflammatory and microbiota-related fertility phenotypes. Its offering combines diagnostic testing with individualized probiotic, nutraceutical, diet, and lifestyle programs intended to restore fertility potential over a multi-month treatment period. Microgenesis appears to operate primarily as a women’s health and fertility diagnostics/platform company rather than a traditional drug developer, with services marketed both through physicians and direct-to-consumer channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microgenesis.